ASI 2017* , ,
Presentations this author is a contributor to:
Mechanisms behind elotuzumab and lenalidomide dual therapy in multiple myeloma (#82)
3:25 PM
Kelden Richardson
Workshop 8: Vaccines and Immunotherapies